Background: Economic evaluation helps policy makers and healthcare payers make decisions on drug listing, coverage, and reimbursement. When economic evaluations are conducted before a product launch, the prices of the pharmaceuticals have to be forecast.
Objective: The aim of this study was to examine the methods of establishing proxy prices and their accuracies compared with actual market prices after the product launch.